147 related articles for article (PubMed ID: 19557878)
1. Low-dose of tacrolimus favors the induction of functional CD4(+)CD25(+)FoxP3(+) regulatory T cells in solid-organ transplantation.
Wang Z; Shi B; Jin H; Xiao L; Chen Y; Qian Y
Int Immunopharmacol; 2009 May; 9(5):564-9. PubMed ID: 19557878
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy of CD4(+)CD25(+) regulatory T cells with low-dose sirolimus, but not calcineurin inhibitors, preserves suppressive function of regulatory T cells and prolongs allograft survival in mice.
Ma A; Qi S; Wang Z; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):553-63. PubMed ID: 19539558
[TBL] [Abstract][Full Text] [Related]
4. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
[TBL] [Abstract][Full Text] [Related]
5. The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins.
Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; Mol W; Weimar W; Baan CC
Clin Exp Immunol; 2010 Aug; 161(2):364-77. PubMed ID: 20528886
[TBL] [Abstract][Full Text] [Related]
6. Clinical rejection and persistent immune regulation in kidney transplant patients.
Hendrikx TK; Klepper M; Ijzermans J; Weimar W; Baan CC
Transpl Immunol; 2009 Jul; 21(3):129-35. PubMed ID: 19398001
[TBL] [Abstract][Full Text] [Related]
7. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
Sewgobind VD; Kho MM; van der Laan LJ; Hendrikx TK; van Dam T; Tilanus HW; IJzermans JN; Weimar W; Baan CC
Nephrol Dial Transplant; 2009 May; 24(5):1635-44. PubMed ID: 19176684
[TBL] [Abstract][Full Text] [Related]
8. Peripherally circulating CD4⁺ FOXP3⁺ CXCR3⁺ T regulatory cells correlate with renal allograft function.
Hoerning A; Köhler S; Jun C; Tebbe B; Fu J; Menke J; Wilde B; Dolff S; Feldkamp T; Briscoe DM; Kribben A; Hoyer PF; Witzke O
Scand J Immunol; 2012 Sep; 76(3):320-8. PubMed ID: 22670785
[TBL] [Abstract][Full Text] [Related]
9. Effect of rapamycin and interleukin-2 on regulatory CD4+CD25+Foxp3+ T cells in mice after allogenic corneal transplantation.
Wang X; Wang W; Xu J; Le Q
Transplant Proc; 2013 Mar; 45(2):528-37. PubMed ID: 23267787
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of CD4+CD25+ regulatory cells combined with low-dose sirolimus and anti-thymocyte globulin delays acute rejection of renal allografts in Cynomolgus monkeys.
Ma A; Qi S; Song L; Hu Y; Dun H; Massicotte E; Dupuis M; Daloze P; Chen H
Int Immunopharmacol; 2011 May; 11(5):618-29. PubMed ID: 21094689
[TBL] [Abstract][Full Text] [Related]
11. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
[TBL] [Abstract][Full Text] [Related]
12. Blockade of chronic graft-versus-host disease by alloantigen-induced CD4+CD25+Foxp3+ regulatory T cells in nonlymphopenic hosts.
Giorgini A; Noble A
J Leukoc Biol; 2007 Nov; 82(5):1053-61. PubMed ID: 17684039
[TBL] [Abstract][Full Text] [Related]
13. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
[TBL] [Abstract][Full Text] [Related]
14. Reduced CD4
Mirzakhani M; Shahbazi M; Akbari R; Oliaei F; Asgharpour M; Nikoueinejad H; Mohammadnia-Afrouzi M
Transpl Immunol; 2020 Jun; 60():101290. PubMed ID: 32240775
[TBL] [Abstract][Full Text] [Related]
15. Cytokines affecting CD4(+) T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4(+)CD25(+) Treg.
Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM
Transpl Immunol; 2013 Dec; 29(1-4):51-9. PubMed ID: 24139939
[TBL] [Abstract][Full Text] [Related]
16. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
[TBL] [Abstract][Full Text] [Related]
17. Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells.
Xia G; Shah M; Luo X
Transl Res; 2009 Feb; 153(2):60-70. PubMed ID: 19138650
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.
Chu ZQ; Ji Q
Transplant Proc; 2013; 45(1):153-6. PubMed ID: 23375290
[TBL] [Abstract][Full Text] [Related]
19. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
20. The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis.
Zhang Y; Wang HB; Chi LJ; Wang WZ
Immunol Lett; 2009 Jan; 122(1):52-7. PubMed ID: 19111574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
